Gene · 2195
Papers4,590
Newest first. Swiss-Prot's references are curated; PubTator's text mining finds papers that name the gene, not always ones about it.
681 to 700 of 4,590
Download this page as JSON| Title | Journal | Year | PMID | Found by | Source |
|---|---|---|---|---|---|
| Nivolumab plus chemoradiotherapy in locally-advanced cervical cancer: the NICOL phase 1 trial. | Nat Commun | 2023 | 37349318 | PubTator, text mining | PubMed |
| Tumor and local lymphoid tissue interaction determines prognosis in high-grade serous ovarian cancer. | Cell Rep Med | 2023 | 37348499 | PubTator, text mining | PubMed |
| Genome sequencing reveals molecular subgroups in oral epithelial dysplasia. | Braz Oral Res | 2023 | 37341234 | PubTator, text mining | PubMed |
| Data mining on identifying diagnosis and prognosis biomarkers in head and neck squamous carcinoma. | Sci Rep | 2023 | 37340028 | PubTator, text mining | PubMed |
| Variable Outcome of Immunotherapy in Advanced Multiple Cutaneous Squamous Cell Carcinomas in Two Patients with Recessive Dystrophic Epidermolysis Bullosa. | Acta Derm Venereol | 2023 | 37338146 | PubTator, text mining | PubMed |
| Potential Alternative Therapeutic Modalities for Management Head and Neck Squamous Cell Carcinoma: A Review. | Cancer Control | 2023 | 37328298 | PubTator, text mining | PubMed |
| Lipid metabolism and rheumatoid arthritis. | Front Immunol | 2023 | 37325667 | PubTator, text mining | PubMed |
| PRR14 acts a novel oncogene activating the PI3K signal pathway in human cutaneous squamous cell carcinoma. | J Cancer | 2023 | 37325059 | PubTator, text mining | PubMed |
| CircFAT1 Promotes the Proliferation and Invasion of Malignant Melanoma through miR375-SLC7A11 Signal Axis. | Anticancer Agents Med Chem | 2023 | 37303180 | PubTator, text mining | PubMed |
| Targeting IGF2BP3 in Cancer. | Int J Mol Sci | 2023 | 37298373 | PubTator, text mining | PubMed |
| Exploring the Functional Roles of Telomere Maintenance 2 in the Tumorigenesis of Glioblastoma Multiforme and Drug Responsiveness to Temozolomide. | Int J Mol Sci | 2023 | 37298208 | PubTator, text mining | PubMed |
| NOVAprep-miR-Cervix: New Method for Evaluation of Cervical Dysplasia Severity Based on Analysis of Six miRNAs. | Int J Mol Sci | 2023 | 37298066 | PubTator, text mining | PubMed |
| Metaplastic Breast Carcinoma in U.S. Population: Racial Disparities, Survival Benefit of Adjuvant Chemoradiation and Future Personalized Treatment with Genomic Landscape. | Cancers (Basel) | 2023 | 37296916 | PubTator, text mining | PubMed |
| A Multi-Omics Overview of Colorectal Cancer to Address Mechanisms of Disease, Metastasis, Patient Disparities and Outcomes. | Cancers (Basel) | 2023 | 37296894 | PubTator, text mining | PubMed |
| ATHENA: an independently validated autophagy-related epigenetic prognostic prediction model of head and neck squamous cell carcinoma. | Clin Epigenetics | 2023 | 37296474 | PubTator, text mining | PubMed |
| The analysis of cathepsin L that mediates cellular SARS-CoV-2 infection leading to COVID-19 in head and neck squamous cell carcinoma. | Front Immunol | 2023 | 37292206 | PubTator, text mining | PubMed |
| Crucial role of the transcription factors family activator protein 2 in cancer: current clue and views. | J Transl Med | 2023 | 37291585 | PubTator, text mining | PubMed |
Clinical and Genomic Characteristics of Patients with Hormone Receptor-Positive, Human Epidermal Growth Factor Receptor 2-Negative Metastatic Breast Cancer Following Progression on Cyclin-Dependent Kinase 4 and 6 Inhibitors. | Clin Cancer Res | 2023 | 37289194 | PubTator, text mining | PubMed |
| Neoadjuvant immunochemotherapy for locally advanced resectable oral squamous cell carcinoma: a prospective single-arm trial (Illuminate Trial). | Int J Surg | 2023 | 37288582 | PubTator, text mining | PubMed |
| Heterogeneity of Target Antigens in Sarcoidosis-Associated Membranous Nephropathy. | Kidney Int Rep | 2023 | 37284677 | PubTator, text mining | PubMed |
gene-search-2026-11-11-0.2.0
Sources 12
- ClinicalTrials.gov's posted results, through CTTI's AACTFreely available. Acknowledgement requested
- ChEMBL, through Open TargetsCC BY-SA 3.0
- ClinicalTrials.govNo license stated
- EMBL-EBI's patent proteinsNo added restrictions. Attribution expected
- GenBank's patent filesNo restrictions from NCBI. Submitters may hold rights
- HGNCCC0
- NCBI GenePublic domain (US government)
- NIH's project files and grant-paper linksPublic domain
- Open TargetsCC0 1.0
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0
Each source's terms
- ClinicalTrials.gov's posted results, through CTTI's AACTClinicalTrials.gov data via Aggregate Analysis of ClinicalTrials.gov (AACT), CTTI. CTTI makes its materials freely available and requests acknowledgement. https://aact.ctti-clinicaltrials.org/documentation/299
- ChEMBL, through Open TargetsCC BY-SA 3.0, for the parts from ChEMBL. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- ClinicalTrials.govnone stated
- EMBL-EBI's patent proteinsEMBL-EBI's patent protein files from the EPO, JPO, KIPO and USPTO. EMBL-EBI: "EMBL-EBI itself places no additional restrictions on the use or redistribution of the data available via its Data Resources and Tools other than those provided by the original data owners" and "EMBL-EBI expects attribution (e.g. in publications, services or products) for the use of any of its Data Resources and Tools." Read on 11 Nov 2026 at https://www.ebi.ac.uk/about/terms-of-use
- GenBank's patent filesGenBank's patent files. NCBI: "NCBI places no restrictions on the use or distribution of the GenBank data. However, some submitters may claim patent, copyright, or other intellectual property rights in all or a portion of the data they have submitted." Read on 11 Nov 2026 at https://www.ncbi.nlm.nih.gov/genbank/about/
- HGNCCC0: https://www.genenames.org/about/license/
- NCBI GeneNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
- NIH's project files and grant-paper linksPublic domain (NIH RePORTER)
- Open TargetsCC0 1.0. Open Targets asks that users cite its latest paper: Buniello et al. 2025, Open Targets Platform: facilitating therapeutic hypotheses building in drug discovery, Nucleic Acids Research 53(D1):D1467, PMID 39657122. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0. UniProt's licence file: "All databases and documents in the UniProt FTP directory may be copied and redistributed freely, without advance permission, provided that this copyright statement is reproduced with each copy." UniProt asks that users cite its latest paper: The UniProt Consortium, UniProt: the Universal Protein Knowledgebase in 2025, Nucleic Acids Research 53:D609-D617, https://doi.org/10.1093/nar/gkae1010. Read on 9 Nov 2026 at https://www.uniprot.org/help/license
ClinicalTrials.gov's data carry an international copyright outside the United States: https://clinicaltrials.gov/about-site/terms-conditions.
For software
Read this list from software.
Twenty rows a page, as JSON. No key.
GET https://conductscience.org/api/genes/v1/2195/papers?page=35